Connect with us

Business

After fighting for legalization, weed smokers face a harsh reality: Symptoms earlier generations didn’t experience make wake-and-bake a new kind of addiction

Published

on



For the past several years, 75-year-old Miguel Laboy has smoked a joint with his coffee every morning. He tells himself he won’t start tomorrow the same way, but he usually does.

“You know what bothers me? To have cannabis on my mind the first thing in the morning,” he said, sparking a blunt in his Brookline, Massachusetts, apartment. “I’d like to get up one day and not smoke. But you see how that’s going.”

Since legalization and commercialization, daily cannabis use has become a defining — and often invisible — part of many people’s lives. High-potency vapes and concentrates now dominate the market, and doctors say they can blur the line between relief and dependence over time so that users don’t notice the shift. Across the country, people who turned to cannabis for help are finding it harder to put down.

Overall, alcohol remains more widely used than cannabis. But starting in 2022, the number of daily cannabis users in the U.S. surpassed that of daily drinkers — a major shift in American habits.

Researchers say the rise has unfolded alongside products that contain far more THC than the marijuana of past decades, including vape oils and concentrates that can reach 80% to 95% THC. Massachusetts, like most states, sets no limit on how strong these products can be.

Doctors warn that daily, high-potency use can cloud memory, disturb sleep, intensify anxiety or depression and trigger addiction in ways earlier generations didn’t encounter. Many who develop cannabis use disorder say it’s hard to recognize the signs because of the widespread belief that marijuana isn’t addictive. Because the consequences tend to creep in gradually — brain fog, irritability, dependence — users often miss when therapeutic use shifts into compulsion.

How a habit becomes an addiction

Laboy, a retired chef, began seeing a substance-use counselor after telling his doctor he felt depressed, unmotivated and increasingly isolated as his drinking and cannabis use escalated.

Naltrexone helped him quit alcohol, but he hasn’t found a way to quit marijuana. Unlike alcohol and opioids, there is no FDA-approved medication to treat cannabis addiction, though research is underway.

Laboy, who first smoked at 18, said marijuana has long soothed symptoms tied to undiagnosed ADHD, childhood trauma and painful experiences — including cancer treatment and his son’s death. Through decades in restaurant kitchens, he considered himself a “functional pothead.”

Lately, though, his use has become compulsive. After retiring, he began vaping 85% THC cartridges.

“These days, I carry two things in my hands: my vape and my cellular — that’s it,” he said. “I’m not proud of it, but it’s the reality.”

Cannabis eases his anxiety and “settles his spirit,” but he’s noticed it affects his concentration. He hopes to learn to read music, but sustaining focus at the piano has grown difficult.

He’s seen an addiction psychiatrist for six months, but he hasn’t been able to cut back. The medical system doesn’t seem equipped to help, he said.

“They’re not ready yet,” Laboy said. “I go to them for help, but all they say is, ‘Try to smoke less.’ I already know that — that’s why I’m there.”

Younger users describe a similar slide — one that begins with relief and ends somewhere harder to define.

Brain fog becomes ‘your new normal’

Kyle, a 20-year-old Boston University student, says cannabis helps him manage panic attacks he’s had since high school. He spoke on the condition that only his first name be used because he buys cannabis illegally.

In the Allston apartment he shares with fraternity brothers, they have a communal bong.

When he’s high, Kyle feels calm — and able to process anxious thoughts and feel a sense of gratitude. But that clarity has become harder to reach when he’s sober.

“I think I was able to do that better a year ago,” he said. “Now I can only do it when I’m high, which is scary.”

He said the brain fog and feeling of detachment develop so gradually they become “your new normal.” Some mornings, he wakes up feeling like an observer in his own life, struggling to recall the day before. “It can be tough to wake up and go, ‘Oh my God, who am I?’” he said.

Still, he doesn’t plan to stop anytime soon.

Kyle says cannabis helps him function — more than seeking professional treatment would. Doctors say that ambivalence is common: many people feel cannabis is both the problem and the solution.

A dream turns into a nightmare

Anne Hassel spent a month in jail and a year on probation for growing cannabis in the 1980s. She cried when Massachusetts’ first dispensaries opened — and left her physical therapy career to get a job at one.

Within a year, though, “my dream job turned into a nightmare,” she said.

Hassel, 58, said some consultants pushed staff to promote high-potency concentrates as “more medicinal,” downplaying their risks. After trying her first dab — a nearly instantaneous, “stupefying” high — she began using 90% THC concentrate several times a day.

Her use quickly became debilitating, she said. She lost interest in things she once loved, like mountain biking. One autumn day, she drove to the woods and turned back without getting out. “I just wanted to go to my friend’s house and dab,” she said. “I hated myself.”

She didn’t seek formal treatment but recovered with the help of a friend. Riding her green motorcycle — once named “Sativa” after her favorite strain — has helped her reconnect to her body and spirit.

“People don’t want to acknowledge what’s going on because legalization was tied to social justice,” she said. “You get swept up in it and don’t recognize the harm until it’s too late.”

Community for those who want to leave

Online, that realization unfolds daily on r/leaves, a Reddit community of more than 380,000 people trying to cut back or quit.

Users describe a similar push-pull — craving the calm cannabis brings, then feeling trapped by the fog. Some write about isolation and regret, saying years of smoking dulled their ambition and presence in relationships. Others post pleas for help from work or doctors’ offices.

Together, they paint a portrait of dependence that is quiet and routine — and difficult to escape.

“When people talk about legalizing a drug, they’re really talking about commercializing it,” said Dave Bushnell, who founded the Reddit group. “We’ve built an industry optimized to sell as much as possible.”

What doctors want people to know

Dr. Jordan Tishler, a former emergency physician who now treats medical cannabis patients in Massachusetts, said low doses of THC paired with high doses of CBD can help some patients with anxiety. Many products have high levels of THC, which can worsen symptoms, he said.

“It’s a medicine,” he said. “It can be useful, but it can also be dangerous — and access without guidance is dangerous.”

Dr. Kevin Hill, an addiction director at Boston’s Beth Israel Deaconess Medical Center who specializes in cannabis use disorder, said the biggest gap is education, among both consumers and clinicians.

“I think adults should be allowed to do what they want as long as it doesn’t hurt anybody else,” but many users don’t understand the risks, Hill said.

He said the conversation shouldn’t be about prohibition but about balance and informed decision-making. “For most people, the risks outweigh the benefits.”



Source link

Continue Reading

Business

What a Walmart CEO contender’s exit reveals about when to move on

Published

on



There’s no such thing as a silver medal in a CEO succession race.

In November, Walmart named U.S. chief John Furner as its next CEO, crowning him the sixth leader in the history of the world’s largest retailer. The decision also quietly closed the door on another highly regarded contender for the corner office: Kath McLay, Walmart International’s CEO and a decade-long veteran of the company. On Thursday, Walmart disclosed that McLay would depart, staying on briefly to ensure a smooth transition.

The sequence was swift, orderly, and entirely unsurprising to those who study corporate succession. Boards rarely say it out loud, but experienced executives understand intuitively that once a CEO is chosen, the long-term prospects for previously whispered-about internal candidates dim almost immediately as power consolidates around the new chief executive. 

That’s why many of the most ambitious leaders in American business don’t linger after a succession decision. They move deliberately, and often quickly, because the moment immediately after a board makes its choice is paradoxically when a near-CEO executive’s market value is at its peak. The executive has just been validated at the highest level—close enough to be seriously considered for the top job—without yet absorbing the reputational drag that can follow prolonged proximity to a decision that didn’t go their way.

In that narrow window, the story is still about capability. Search firms and directors see a leader who was trusted with scale, complexity, and board scrutiny, not someone who failed to clear the final hurdle. 

When Jeff Immelt was named CEO of General Electric in 2001, the decision concluded one of the most closely watched succession contests in modern corporate history. Among the executives developed as credible successors was Bob Nardelli, then president and CEO of GE Power Systems. Nardelli didn’t stay to see how it might play out. Within months, he left GE to become Home Depot’s CEO.

A decade later, a different scenario unfolded at Apple, but with a similar outcome. Retail chief Ron Johnson had transformed Apple’s stores into an industry-defining, highly profitable global business and was widely viewed internally as CEO-caliber. Apple’s board had long centered its succession plans on Tim Cook, and when Cook was formally named successor to Steve Jobs, it effectively closed the door on a CEO path for Johnson. He left soon after to take the top job at J.C. Penney.

The executives who leave quickly aren’t being disloyal; they’re being realistic. Remaining too long after a succession decision can quietly erode an executive’s standing, both internally and externally, as the narrative shifts from “next in line” to “still waiting.”

At Ford Motor Co., president Joe Hinrichs was widely viewed as a leading CEO contender. When the board selected Jim Hackett in 2017, Hinrichs left not long afterward. Five years later, he resurfaced as CEO of transportation company CSX. Similarly, several senior Disney executives left or were sidelined after Bob Chapek was chosen as CEO in 2020. Most notably, Kevin Mayer, Disney’s head of direct-to-consumer and international, and a widely assumed CEO contender, departed within months to briefly become CEO of TikTok.

There are exceptions. But they tend to follow a different arc.

Although longtime Nike insider Elliott Hill was not passed over in a formal succession contest, he was widely viewed as CEO-ready when the board opted for an external hire in 2020. Hill stayed on for several years and later retired. Only after performance pressures mounted and the company embarked on a strategic reset did Nike’s board reverse course, asking Hill to return as CEO in 2024. Even then, such boomerangs remain exceedingly rare.

McLay’s departure from Walmart fits the dominant pattern. By exiting promptly while remaining to support a defined transition, she preserves both her reputation and her leverage. She leaves as an executive who was close enough to be seriously considered—not one who stayed long enough to be diminished by the process.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.



Source link

Continue Reading

Business

Crypto market reels in face of tariff turmoil, Bitcoin falls below $90,000 as key legislation stalls

Published

on



If you don’t like the price of Bitcoin, wait five minutes, and it will change. The major cryptocurrency’s volatility has been on full display to start the year, this time dipping about 7% since last week to its current price of just under $90,000 as of mid-day Tuesday.

Other cryptocurrencies have also slid. Ethereum is down 11% in the last six days to its current price of about $3,000, and Solana is down about 14% during that time to its price of about $127. 

The dip comes as President Donald Trump threatened European nations with tariffs as they pushed back against his plans to take over Greenland, causing markets to scramble. Meanwhile, crypto markets faced an additional headwind as key legislation for the industry, known as the Clarity Act, became stalled after industry giant Coinbase unexpectedly withdrew its support late last week. 

“President Trump’s threat to impose tariffs on Europe has put Bitcoin under pressure,” said Russell Thompson, chief investment officer at Hilbert Group. “The postponement of the Clarity Act in the Senate committee mainly due to concerns from Coinbase eliminated a large amount of positive sentiment in the market.”

Coinbase CEO Brian Armstrong objected to the Clarity Act primarily on grounds that crypto owners would not be able to earn yield from stablecoins. The new uncertainty over the bill, which many assumed was on a smooth path towards a Presidential signature, has shaken the price not just of crypto assets but also the share price of companies exposed to digital assets. 

It’s uncertain whether the current headwinds will fade anytime soon. Trump has made his intentions of taking control of Greenland clear. When a group of European nations expressed solidarity with the Danish, he threatened those countries with tariffs, saying he would not back down until Greenland was purchased. Bitcoin and other risk assets subsequently fell, along with major stock indices, while the price of gold rose.

It’s not all gloom and doom for crypto, at least according to some analysts, who view Bitcoin’s correlation with macroeconomic forces as confirmation that digital assets have finally gone mainstream. 

“Bitcoin’s reactivity is another sign of its increasing integration with broader macroeconomic forces, signaling maturation rather than fragility, even as short-term volatility continues,” said Beto Aparicio, senior manager of strategic finance at Offchain Labs.

Join us at the Fortune Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.



Source link

Continue Reading

Business

The 9 most disruptive deals of Trump’s first year back in the White House

Published

on


President Trump lives on deals: “That’s what I do—I do deals,” he once told Bob Woodward. On the one-year anniversary of his second presidency, he’s pushing hard to make his biggest, most disruptive deal ever, one that would bring Greenland under the control of the U.S.—and the global business community is still scrambling to adapt to his approach. Here are nine of Trump’s most unorthodox deals from the past year.

Nine deals that shook the business world

April 2, 2025: Reciprocal tariffs

Trump imposes “reciprocal tariffs” on 57 countries, with each tariff understood as an opening bid in a negotiation. Several countries have since made deals. The one-on-one negotiations, unlike the multilateral system of the past 80 years, can be chaotic for companies and economies

June 13: U.S. Steel “Golden Share”

In return for allowing Nippon Steel to buy U.S. Steel, Trump requires that the U.S. receive several powers over the company, including total power over all the board’s independent directors and vetoes over locations of offices and factories. 

July 10: MP Materials

The U.S. pays $400 million for a large equity share in MP and signs a contract to buy all of MP’s rare earth magnets for 10 years. The reason for the equity stake was not disclosed.

July 14: Nvidia, Part 1

JADE GAO—AFP/Getty Images

Trump reverses the U.S. ban on selling Nvidia H20 chips to China in exchange for Nvidia paying the U.S. 15% of the revenue.

July 23: Columbia University

LYA CATTEL/Getty Images

The Trump administration restores $400 million of canceled federal research funding for the university under an unprecedented multipoint deal. For example, Columbia must supply data to the federal government for all applicants, broken down by race, “color,” GPA, and standardized test performance. A few other schools later make similar deals.

August 6: Apple

Bonnie Cash—UPI/Bloomberg/Getty Images

At a public appearance with Trump, CEO Tim Cook announces Apple will invest an additional $100 billion in the U.S. over four years; Trump announces Apple will be exempt from a planned tariff on imported chips that would have doubled the price of iPhones in the U.S.

August 22: Intel

Justin Sullivan—Getty Images

Intel trades the U.S. government a 9.9% equity stake in exchange for $8.9 billion that might already be owed to Intel under the CHIPS and Science Act. The deal is unusual because the company was not in immediate danger or significantly affecting the economy.

December 8: Nvidia, Part 2:

Trump reverses the U.S. ban on selling powerful Nvidia H200 chips in exchange for Nvidia paying the U.S. 25% of the revenue. Both Nvidia deals are unusual because the payments to the U.S., based on exports, appear to be forbidden by the Constitution. 

December 19: Pharma

Alex Wong—Getty Images

Nine pharmaceutical companies make deals with Trump that are intended to lower drug prices. This is unusual because Trump negotiated separate deals with each company, and the terms have not been released.

All eyes this week will be watching President Trump at the World Economic Forum in Davos, where the president has hinted he’ll announce some high-stakes agreements. Expect the unexpected.

A version of this piece appears in the February/March 2026 issue of Fortune.



Source link

Continue Reading

Trending

Copyright © Miami Select.